{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:50:27Z","timestamp":1745859027533},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00063-017-0270-4","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T04:37:47Z","timestamp":1491367067000},"page":"192-198","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antibiotic Stewardship am Beispiel der Staphylococcus aureus Bakteri\u00e4mie"],"prefix":"10.1007","volume":"112","author":[{"given":"S.","family":"Weis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"270_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jinf.2011.03.003","volume":"62","author":"H Asgeirsson","year":"2011","unstructured":"Asgeirsson H, Kristjansson M, Kristinsson KG et\u00a0al (2011) Staphylococcus aureus bacteraemia \u2013 Nationwide assessment of treatment adequacy and outcome. J\u00a0Infect 62:339\u2013346","journal-title":"J Infect"},{"key":"270_CR2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s15010-014-0633-1","volume":"42","author":"JP Borde","year":"2014","unstructured":"Borde JP, Batin N, Rieg S et al (2014) Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a\u00a0200-bed community hospital. Infection 42:713\u2013719","journal-title":"Infection"},{"key":"270_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS et\u00a0al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1\u201312","journal-title":"Clin Infect Dis"},{"key":"270_CR4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, Macdonald BB, Peacock JE Jr. et\u00a0al (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322\u2013332","journal-title":"Medicine (Baltimore)"},{"key":"270_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, Peacock JE Jr., Musher DM et\u00a0al (2003) Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a\u00a0prospective multicenter study. Medicine (Baltimore) 82:333\u2013339","journal-title":"Medicine (Baltimore)"},{"key":"270_CR6","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a\u00a0randomized trial. JAMA 290:2588\u20132598","journal-title":"JAMA"},{"issue":"Suppl 4","key":"270_CR7","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1086\/598186","volume":"48","author":"GR Corey","year":"2009","unstructured":"Corey GR (2009) Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis 48(Suppl 4):S254\u2013S259","journal-title":"Clin Infect Dis"},{"key":"270_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN et al (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a\u00a0meta-analysis. Clin Infect Dis 36:53\u201359","journal-title":"Clin Infect Dis"},{"key":"270_CR9","volume-title":"S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus","author":"K With De","year":"2013","unstructured":"De With K, Allerberger F, Amann S et al (2013) S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/092-001l_S3_Antibiotika_Anwendung_im_Krankenhaus_2013-verlaengert.pdf . Zugegriffen: 15 Feb 2017"},{"key":"270_CR10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/514686","volume":"27","author":"VG Fowler Jr.","year":"1998","unstructured":"Fowler VG Jr., Sanders LL, Sexton DJ et\u00a0al (1998) Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27:478\u2013486","journal-title":"Clin Infect Dis"},{"key":"270_CR11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/cid\/cit730","volume":"58","author":"BL Fries","year":"2014","unstructured":"Fries BL, Licitra C, Crespo A et\u00a0al (2014) Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis 58:598\u2013599","journal-title":"Clin Infect Dis"},{"key":"270_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/j.1552-4604.1995.tb04742.x","volume":"35","author":"J Gath","year":"1995","unstructured":"Gath J, Charles B, Sampson J et\u00a0al (1995) Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients. J\u00a0Clin Pharmacol 35:31\u201336","journal-title":"J Clin Pharmacol"},{"key":"270_CR13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","volume":"57","author":"CG Gemmell","year":"2006","unstructured":"Gemmell CG, Edwards DI, Fraise AP et al (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J\u00a0Antimicrob Chemother 57:589\u2013608","journal-title":"J Antimicrob Chemother"},{"key":"270_CR14","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ et\u00a0al (2015) 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart\u00a0J 36:3075\u20133128","journal-title":"Eur Heart J"},{"key":"270_CR15","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/jac\/dkt292","volume":"68","author":"S Hansen","year":"2013","unstructured":"Hansen S, Sohr D, Piening B et\u00a0al (2013) Antibiotic usage in German hospitals: results of the second national prevalence study. J\u00a0Antimicrob Chemother 68:2934\u20132939","journal-title":"J Antimicrob Chemother"},{"key":"270_CR16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","volume":"312","author":"TL Holland","year":"2014","unstructured":"Holland TL, Arnold C, Fowler VG Jr. (2014) Clinical management of Staphylococcus aureus bacteremia: a\u00a0review. JAMA 312:1330\u20131341","journal-title":"JAMA"},{"key":"270_CR17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2010.01.015","volume":"123","author":"H Honda","year":"2010","unstructured":"Honda H, Krauss MJ, Jones JC et\u00a0al (2010) The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 123:631\u2013637","journal-title":"Am J Med"},{"key":"270_CR18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13063-015-0973-x","volume":"16","author":"AJ Kaasch","year":"2015","unstructured":"Kaasch AJ, Fatkenheuer G, Prinz-Langenohl R et al (2015) Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a\u00a0randomized controlled trial. Trials 16:450","journal-title":"Trials"},{"key":"270_CR19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/374621","volume":"187","author":"KB Laupland","year":"2003","unstructured":"Laupland KB, Church DL, Mucenski M et al (2003) Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J\u00a0Infect Dis 187:1452\u20131459","journal-title":"J Infect Dis"},{"key":"270_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","volume":"19","author":"KB Laupland","year":"2013","unstructured":"Laupland KB, Lyytikainen O, Sogaard M et al (2013) The changing epidemiology of Staphylococcus aureus bloodstream infection: a\u00a0multinational population-based surveillance study. Clin Microbiol Infect 19:465\u2013471","journal-title":"Clin Microbiol Infect"},{"key":"270_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2334-12-85","volume":"12","author":"R Lenz","year":"2012","unstructured":"Lenz R, Leal JR, Church DL et\u00a0al (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85","journal-title":"BMC Infect Dis"},{"key":"270_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jinf.2003.10.010","volume":"48","author":"O Lesens","year":"2004","unstructured":"Lesens O, Hansmann Y, Brannigan E et\u00a0al (2004) Positive surveillance blood culture is a\u00a0predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J\u00a0Infect 48:245\u2013252","journal-title":"J Infect"},{"key":"270_CR23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/502156","volume":"24","author":"O Lesens","year":"2003","unstructured":"Lesens O, Methlin C, Hansmann Y et\u00a0al (2003) Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a\u00a0prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24:890\u2013896","journal-title":"Infect Control Hosp Epidemiol"},{"key":"270_CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285\u2013292","journal-title":"Clin Infect Dis"},{"key":"270_CR25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","volume":"57","author":"LE Lopez-Cortes","year":"2013","unstructured":"Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J et al (2013) Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 57:1225\u20131233","journal-title":"Clin Infect Dis"},{"key":"270_CR26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus infections. N\u00a0Engl J Med 339:520\u2013532","journal-title":"N Engl J Med"},{"key":"270_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","volume":"5","author":"FB Mayr","year":"2014","unstructured":"Mayr FB, Yende S, Angus DC (2014) Epidemiology of severe sepsis. Virulence 5:4\u201311","journal-title":"Virulence"},{"key":"270_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"key":"270_CR29","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","volume":"15","author":"AS Michalopoulos","year":"2011","unstructured":"Michalopoulos AS, Livaditis IG, Gougoutas V (2011) The revival of fosfomycin. Int J Infect Dis 15:e732\u2013e739","journal-title":"Int J Infect Dis"},{"issue":"Suppl 2","key":"270_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1444-0903.2005.00977.x","volume":"35","author":"DH Mitchell","year":"2005","unstructured":"Mitchell DH, Howden BP (2005) Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med\u00a0J 35(Suppl 2):17\u201324","journal-title":"Intern Med J"},{"key":"270_CR31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkt362","volume":"69","author":"C Murray","year":"2014","unstructured":"Murray C, Shaw A, Lloyd M et\u00a0al (2014) A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections. J\u00a0Antimicrob Chemother 69:515\u2013518","journal-title":"J Antimicrob Chemother"},{"key":"270_CR32","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jac\/dkt108","volume":"68","author":"JL Nissen","year":"2013","unstructured":"Nissen JL, Skov R, Knudsen JD et al (2013) Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a\u00a0retrospective, propensity-score-adjusted case-control and cohort analysis. J\u00a0Antimicrob Chemother 68:1894\u20131900","journal-title":"J Antimicrob Chemother"},{"key":"270_CR33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD et\u00a0al (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a\u00a0randomized trial. Am J Respir Crit Care Med 177:498\u2013505","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"270_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens Jr.","year":"2008","unstructured":"Owens RC Jr., Donskey CJ, Gaynes RP et al (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):19\u201331","journal-title":"Clin Infect Dis"},{"key":"270_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ235","author":"BR Palraj","year":"2015","unstructured":"Palraj BR, Baddour LM, Hess EP et\u00a0al (2015) Predicting Risk of Endocarditis Using a\u00a0Clinical Tool (PREDICT): Scoring system to guide use of echocardiography in the management of staphylococcus aureus bacteremia. Clin Infect Dis. doi: 10.1093\/cid\/civ235","journal-title":"Clin Infect Dis"},{"key":"270_CR36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","volume":"17","author":"M Paul","year":"2011","unstructured":"Paul M, Zemer-Wassercug N, Talker O et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581\u20131586","journal-title":"Clin. Microbiol. Infect."},{"key":"270_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1552-4604.1983.tb01787.x","volume":"23","author":"K Polasa","year":"1983","unstructured":"Polasa K, Krishnaswamy K (1983) Effect of food on bioavailability of rifampicin. J\u00a0Clin Pharmacol 23:433\u2013437","journal-title":"J Clin Pharmacol"},{"key":"270_CR38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrmicro1384","volume":"4","author":"RA Proctor","year":"2006","unstructured":"Proctor RA, Von Eiff C, Kahl BC et\u00a0al (2006) Small colony variants: a\u00a0pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295\u2013305","journal-title":"Nat Rev Microbiol"},{"key":"270_CR39","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/cid\/ciw665","volume":"63","author":"R Pushkin","year":"2016","unstructured":"Pushkin R, Iglesias-Ussel MD, Keedy K et al (2016) A randomized study evaluating oral Fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of-care antibiotics for treatment of prosthetic joint infections: a newly identified drug-drug interaction. Clin Infect Dis 63:1599\u20131604","journal-title":"Clin Infect Dis"},{"key":"270_CR40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0030-1256879","volume":"6","author":"S Rieg","year":"2011","unstructured":"Rieg S, Kern WV (2011) Die nosokomiale Staphylococcus aureus-Bakteri\u00e4mie. Krankenhaushyg Up2date 6:261\u2013272","journal-title":"Krankenhaushyg Up2date"},{"issue":"Suppl 1","key":"270_CR41","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2008.06.006","volume":"32","author":"E Rubinstein","year":"2008","unstructured":"Rubinstein E (2008) Staphylococcus aureus bacteraemia with known sources. Inter J Antimicrob Agents 32(Suppl 1):S18\u2013S20","journal-title":"Inter J Antimicrob Agents"},{"key":"270_CR42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotschafer JC et al (2009) Vancomycin therapeutic guidelines: a\u00a0summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49:325\u2013327","journal-title":"Clin Infect Dis"},{"key":"270_CR43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/cit610","volume":"58","author":"S Schmitt","year":"2014","unstructured":"Schmitt S, Mcquillen DP, Nahass R et\u00a0al (2014) Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 58:22\u201328","journal-title":"Clin Infect Dis"},{"key":"270_CR44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher ME, Mouton JW et al (2016) Current evidence on hospital antimicrobial stewardship objectives: a\u00a0systematic review and meta-analysis. Lancet Infect Dis 16:847\u2013856","journal-title":"Lancet Infect Dis"},{"key":"270_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","volume":"11","author":"ML Schweizer","year":"2011","unstructured":"Schweizer ML, Furuno JP, Harris AD et al (2011) Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 11:279","journal-title":"BMC Infect Dis"},{"key":"270_CR46","volume-title":"MiQ Blutkulturdiagnostik Sepsis, Endokarditis, Katheterinfektionen, Teil I","author":"H Seifert","year":"2007","unstructured":"Seifert H, Abele-Horn M, F\u00e4tkenheuer G et al (2007) MiQ Blutkulturdiagnostik Sepsis, Endokarditis, Katheterinfektionen, Teil I"},{"key":"270_CR47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2011.05.005","volume":"63","author":"P Sendi","year":"2011","unstructured":"Sendi P, Banderet F, Graber P et\u00a0al (2011) Periprosthetic joint infection following Staphylococcus aureus bacteremia. J\u00a0Infect 63:17\u201322","journal-title":"J Infect"},{"key":"270_CR48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s15010-016-0874-2","volume":"44","author":"C Stein","year":"2016","unstructured":"Stein C, Makarewicz O, Forstner C et al (2016) Should daptomycin-rifampin combinations for MSSA\/MRSA isolates be avoided because of antagonism? Infection 44:499\u2013504","journal-title":"Infection"},{"key":"270_CR49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","volume":"72","author":"S Tubiana","year":"2016","unstructured":"Tubiana S, Duval X, Alla F et\u00a0al (2016) The VIRSTA score, a\u00a0prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J\u00a0Infect 72:544\u2013553","journal-title":"J Infect"},{"key":"270_CR50","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1086\/656047","volume":"202","author":"L Tuchscherr","year":"2010","unstructured":"Tuchscherr L, Heitmann V, Hussain M et al (2010) Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J\u00a0Infect Dis 202:1031\u20131040","journal-title":"J Infect Dis"},{"key":"270_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","volume":"72","author":"M Vogel","year":"2015","unstructured":"Vogel M, Schmitz RP, Hagel S et al (2015) Infectious disease consultation for Staphylococcus aureus bacteremia \u2013 A systematic review and meta-analysis. J\u00a0Infect 72:19\u201328","journal-title":"J Infect"},{"key":"270_CR52","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1055\/s-0041-102453","volume":"140","author":"S Weis","year":"2015","unstructured":"Weis S, Kaasch AJ, Rieg S et\u00a0al (2015) Staphylococcus aureus bacteremia \u2013 a\u00a0distinct entity. Dtsch Med Wochenschr 140:982\u2013989","journal-title":"Dtsch Med Wochenschr"},{"key":"270_CR53","volume-title":"Antimicrobial resistance: global report on surveillance","author":"Who","year":"2014","unstructured":"Who (2014) Antimicrobial resistance: global report on surveillance. WHO, Geneva"},{"key":"270_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02015-16","author":"EJ Zasowski","year":"2016","unstructured":"Zasowski EJ, Trinh TD, Claeys KC et al (2016) A multicenter observational study of Ceftaroline Fosamil for Methicillin-resistant staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. doi: 10.1128\/aac.02015-16","journal-title":"Antimicrob Agents Chemother"},{"key":"270_CR55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0962-8479(95)90551-0","volume":"76","author":"C Zent","year":"1995","unstructured":"Zent C, Smith P (1995) Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide. Tuber Lung Dis 76:109\u2013113","journal-title":"Tuber Lung Dis"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-017-0270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-017-0270-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-017-0270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:12:16Z","timestamp":1498385536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-017-0270-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1007\/s00063-017-0270-4","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}